Rapid Novor Inc. Launches REmAb™ Antibody Protein Sequencing Services on Science Exchange


PALO ALTO, CA, January 25, 2018 – Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D) services, announced a partnership with Rapid Novor Inc to offer its REmAb™ Antibody Protein Sequencing Services to scientists around the world using Science Exchange’s R&D platform. Rapid Novor, Inc. is a Kitchener-Waterloo […]

Read More…

Meet Service Providers with ADC (Antibody-Drug Conjugate) Expertise


The excitement around ADCs for treating cancer stems from the realization that traditional, small-molecule cytotoxic drugs and radiation are still some of the most potent anticancer agents, and that targeting them by tethering them to antibodies might bypass some of the side effects. The recent founding investment by Johnson & Johnson of the ADC-focused startup, […]

Read More…